Pamela Furman Forrest
Partner, King & Spalding
Pamela Furman Forrest is a partner in King & Spalding’s FDA & Life Sciences Practice Group. Ms. Forrest joined the firm in 2007, and has nearly 20 years of experience in advising clients on a broad range of FDA regulatory issues. Her practice focuses on FDA medical device matters, including premarket notification, premarket approval, product recalls, Medical Device Reporting (MDR), Quality System Regulation (QSR) compliance, establishment registration and device listing, labeling and promotion, reclassification, import/export issues, Investigational Device Exemption (IDE) requirements, and combination product issues. In addition, Ms. Forrest frequently assists medical device manufacturers, investment banks, and private equity funds with due diligence evaluations of FDA-regulated companies.
Ms. Forrest has written and spoken extensively on various aspects of FDA regulation of medical devices, and has testified before several State legislative committees regarding medical device legal and regulatory issues.
Ms. Forrest graduated summa cum laude, Phi Beta Kappa, from Yale University in 1988, with a Bachelor of Arts in political science. She received her law degree from Stanford Law School in 1994. Ms. Forrest has been named by the Best Lawyers in America guide as one of the best FDA lawyers in the country.